Zamira V. Riascos-Diaz
Barcelona, CT 08035, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Photocaged Chloroquine Derivatives for the Light-Dependent Inhibition of Autophagy in Cancer Stem Cells.
Journal: ACS chemical biology
Published: March 24, 2026
Corrigendum to 'Preclinical evaluation of several polymeric micelles identifies Soluplus®-docetaxel as the most effective candidate in multiple glioblastoma models' [Journal of Controlled Release (2025) 381:113616].
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 09, 2025
Targeted nanoliposomes to improve enzyme replacement therapy of Fabry disease.
Journal: Science advances
Published: December 13, 2024
Preclinical evaluation of several polymeric micelles identifies Soluplus®-docetaxel as the most effective candidate in multiple glioblastoma models.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 10, 2024
Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 05, 2024
The Nanotechnology-Based Approaches against Kirsten Rat Sarcoma-Mutated Cancers.
Journal: Pharmaceutics
Published: April 15, 2023
Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide.
Journal: International journal of molecular sciences
Published: August 17, 2022
Extracellular vesicles secreted by triple-negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs.
Journal: International journal of cancer
Published: July 28, 2022
Pluronic F127 micelles improve the stability and enhance the anticancer stem cell efficacy of citral in breast cancer.
Journal: Nanomedicine (London, England)
Published: June 23, 2021
Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 27, 2020
Last Updated: 09/26/2026